Jonathan L. Coffman PhD

Jon leads the Bioprocess Technologies and Engineering (BTE) function in Biopharmaceutical Development at AstraZeneca. He is responsible for the development of transformative new process technologies and engineering solutions in support of the AZ biologics portfolio. BTE is a specialized function created to ensure leadership within bioprocess engineering and bio-manufacturing technologies within AZ. He was recently inducted as an ACS Fellow.

Jon is a thought leader within Biologics Process Sciences with over 27 years of experience in major biopharmaceutical companies, including 15 years at Pfizer (formerly Wyeth Biopharma and Genetics Institute) and 6 years at Boehringer Ingelheim (BI). Jon is a strong technical leader who has pioneered the development of novel purification technologies while at Wyeth/Pfizer and most recently continuous manufacturing technologies at BI. Much of his work has been recognized via strong peer-reviewed publications records and patents. Jon received his BS in Chemical Engineering from the University of Maine and his Ph.D. in Chemical Engineering from the University of Wisconsin, Madison. Dr. Jon Coffman is the Global Head of Innovation, and Technology at Boehringer Ingelheim in Fremont, California. Jon and his team are instrumental in driving the implementation of AstraZeneca’s bioprocessing innovation vision.